Selecting the ‘best’ CDMO for you

Today, startups and established companies alike are looking to extend their runways by conserving capital. Achieving greater value for what you require is a great method for capital conservation. Contracting with the ‘right’ service provider is key. Select a provider that’s compliant, established, experienced and capable, while offering as many of the services you require under one roof. The more efficient your selected provider is the more time you can spend doing what you do best…innovating!

If you’re developing a biotherapeutic destined for the clinic, choose a contract development & manufacturing organization (CDMO) able to produce both pre-clinical and clinical supplies to support your development efforts. It’s preferable, as the sponsor, for you to select a provider that offers end-to-end capabilities, avoiding the need to enlist a stable of service providers to get your product into the clinic.

Join us for a pizza lunch and interactive presentation describing your options as a sponsor developing a biotherapeutic. We'll discuss cell line development, analytical method development, upstream and downstream development, as well as formulation development ahead of pre-clinical and clinical manufacturing of drug substance (DS), as well as drug product. The conversation will culminate in the importance of Quality Assurance and Regulatory support.

The discussion and Pizza Lunch will be hosted by Dave Monson,

local Executive Director at LUPIN Biotech, an India-based biosimilars producer and CDMO.

What You’ll Learn

• The differences between CDMO service providers
• The benefits of choosing the ‘right’ provider
• A staged or milestone-based approach
• Optimizing efficiency
• Your needs and the future

Whether you need pre-clinical supplies, are moving into the clinic or scaling up for the future, this discussion will provide perspective on the options available to you, as you grow your company and take it to the next level.